Seretide DMI Evohaler 25/125mcg Spray 1 ‘S
Description
- Seretide DMI Evohaler 25/125mcg Spray 1 ‘S contains Salmeterol Xinafoate and Fluticasone Propionate which is a combination of steroid and bronchodilator used to treat Obstructive airway diseases
- Seretide DMI Evohaler 25/125mcg Spray 1 ‘S is indicated in the treatment of Asthma, and Chronic Obstructive Pulmonary Diseases
- Seretide DMI Evohaler 25/125mcg Spray 1 ‘S prevents asthma attacks and flare-ups in COPD associated with Emphysema or Chronic bronchitis
- Adults: 2 inhalations twice a day at lowest effective inhaled corticosteroid dose
- Children above 4 yrs: 2 inhalations of Seretide DMI Evohaler 25/125mcg Spray 1 ‘S 25/50 preparation twice daily
Additional information
Type | Spray |
---|---|
Feature | 25/125mcg |
Unit | 'S |
Formula | Fluticasone |
Composition | Fluticasone 125 mcg + Salmeterol 25 mcg |
Brand | GSK Consumer Healthcare |
Prescription Required | Yes |